press to zoom

press to zoom

press to zoom

press to zoom
↑​Click to see more ↑

Well-known magazine ”Life Science Review”: Taiwanese PhD entrepreneur, breaking through the technical bottleneck of CTC

The international magazine《Life Science Review》published in July 2021: Introduce the latest circulating tumor cell (CTC) technology, which is the core technology of CytoAurora, can be applied to early cancer treatment, monitoring, and therapeutic effects. Its various roles in auxiliary diagnosis provide reference basis for companion diagnosis.

Research Papers

Published research papers

圖片 25.png


CytoAurora participate in academic activities

圖片 11.png